KIF1A

JANUARY 13, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A two-kinesin mechanism controls neurogenesis in the developing brain As we bring in the New Year with this week’s #ScienceSaturday we’re excited to share research from long-time Research Network

DNA 105

DNA Regulations Drug Development Disease 105

Covalent Modifiers

JANUARY 13, 2024

Prof. Dr. Thomas Kodadek Angewandte Chemie International Edition 2024 e202316726 [link] Many of the highest priority targets in a wide range of disease states are difficult-to-drug proteins. The development of reversible small molecule inhibitors for the active sites of these proteins with sufficient affinity and residence time on-target is an enormous challenge.

Small Molecule 77

Small Molecule International Disease Drugs 77

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and Teva and is included in two NDAs. It is available from one supplier. There… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Perficient: Drug Development

JANUARY 13, 2024

In the ever-evolving landscape of assistive technology, adaptive computer interfaces stand at the forefront of innovation, unlocking new possibilities for individuals with multiple or compound disabilities. By seamlessly integrating with mobility aids, these interfaces bridge the gap between users and digital environments, empowering them to communicate, work, and engage with the world in ways that were once thought impossible.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from three suppliers. There are four patents… The post New patent for Boehringer Ingelheim drug PRADAXA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drugs.com

JANUARY 13, 2024

SATURDAY, Jan. 13, 2024 -- In the middle of winter when sunshine can be hard to come by, it's tough to get enough vitamin D, but one expert has some advice.“Vitamin D is well known to support bone health, but it also plays a role in the health of.

52

52

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents… The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for KOSELUGO Koselugo is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting… The post New patent for Astrazeneca drug KOSELUGO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for AUSTEDO+XR Austedo Xr is a drug marketed by Teva and is included in one NDA. It is available from one supplier. There are nine patents… The post New patent for TEVA drug AUSTEDO XR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for DHIVY Dhivy is a drug marketed by Avion Pharms and is included in one NDA. It is available from one supplier. There are two patents… The post New patent for Avion Pharms drug DHIVY appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

JANUARY 13, 2024

Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent for Sun Pharm drug WINLEVI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59